Mélanie Joly · Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, Innovation, Science and Economic Development Canada (ISED)
SRF application. The company presently has an application with the Strategic Response Fund for funding considering for an expansion at our Mississauga Ontario site. While it is at an advanced stage and near a decision, I may have contact with politicians and applicable personnel where it is raised and requires my declaration herein. Topics of discussion would be on status and timing for approval and public notification of approval. Such contact will be in person, though calls or emails..Read more
Mélanie Joly · Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, Innovation, Science and Economic Development Canada (ISED)
232 tariffs. As of Sept. 30th, 100% tariffs apply to Canada for commercial drug shipments to the US. The companies' goal is to ensure this issue is on the radar of our Federal government administrations (e.g. ISED) and politicians. I plan to contact their offices (calls, emails, in person where possible) to make them aware of the risk to the Canadian CDMO industry, manufacturing jobs, and to Canada's Life Science commercialization strategy. My goal is for this issue to be on the agenda to address by our trade negotiators if and when trade negitiations resume so they can be reduced to something reasonable (e.g. Europe is 15% whereas Canada is 100%).Read more
Dominic LeBlanc · President of the King’s Privy Council for Can. & Minister resp. for Can.–U.S. Trade, Intergov. Affairs, Int. Trade & One Can. Economy, Privy Council Office (PCO)
232 tariffs. As of Sept. 30th, 100% tariffs apply to Canada for commercial drug shipments to the US. The companies' goal is to ensure this issue is on the radar of our Federal government administrations (e.g. ISED) and politicians. I plan to contact their offices (calls, emails, in person where possible) to make them aware of the risk to the Canadian CDMO industry, manufacturing jobs, and to Canada's Life Science commercialization strategy. My goal is for this issue to be on the agenda to address by our trade negotiators if and when trade negitiations resume so they can be reduced to something reasonable (e.g. Europe is 15% whereas Canada is 100%).Read more
Simone Racanelli · Office of the Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, House of Commons
232 tariffs. As of Sept. 30th, 100% tariffs apply to Canada for commercial drug shipments to the US. The companies' goal is to ensure this issue is on the radar of our Federal government administrations (e.g. ISED) and politicians. I plan to contact their offices (calls, emails, in person where possible) to make them aware of the risk to the Canadian CDMO industry, manufacturing jobs, and to Canada's Life Science commercialization strategy. My goal is for this issue to be on the agenda to address by our trade negotiators if and when trade negitiations resume so they can be reduced to something reasonable (e.g. Europe is 15% whereas Canada is 100%).Read more
Simone Racanelli · Office of the Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, House of Commons
232 tariffs. As of Sept. 30th, 100% tariffs apply to Canada for commercial drug shipments to the US. The companies' goal is to ensure this issue is on the radar of our Federal government administrations (e.g. ISED) and politicians. I plan to contact their offices (calls, emails, in person where possible) to make them aware of the risk to the Canadian CDMO industry, manufacturing jobs, and to Canada's Life Science commercialization strategy. My goal is for this issue to be on the agenda to address by our trade negotiators if and when trade negitiations resume so they can be reduced to something reasonable (e.g. Europe is 15% whereas Canada is 100%).Read more
232 tariffs. As of Sept. 30th, 100% tariffs apply to Canada for commercial drug shipments to the US. The companies' goal is to ensure this issue is on the radar of our Federal government administrations (e.g. ISED) and politicians. I plan to contact their offices (calls, emails, in person where possible) to make them aware of the risk to the Canadian CDMO industry, manufacturing jobs, and to Canada's Life Science commercialization strategy. My goal is for this issue to be on the agenda to address by our trade negotiators if and when trade negitiations resume so they can be reduced to something reasonable (e.g. Europe is 15% whereas Canada is 100%).Read more
SRF application. The company presently has an application with the Strategic Response Fund for funding considering for an expansion at our Mississauga Ontario site. While it is at an advanced stage and near a decision, I may have contact with politicians and applicable personnel where it is raised and requires my declaration herein. Topics of discussion would be on status and timing for approval and public notification of approval. Such contact will be in person, though calls or emails..Read more
232 tariffs. As of Sept. 30th, 100% tariffs apply to Canada for commercial drug shipments to the US. The companies' goal is to ensure this issue is on the radar of our Federal government administrations (e.g. ISED) and politicians. I plan to contact their offices (calls, emails, in person where possible) to make them aware of the risk to the Canadian CDMO industry, manufacturing jobs, and to Canada's Life Science commercialization strategy. My goal is for this issue to be on the agenda to address by our trade negotiators if and when trade negitiations resume so they can be reduced to something reasonable (e.g. Europe is 15% whereas Canada is 100%).
232 tariffs. As of Sept. 30th, 100% tariffs apply to Canada for commercial drug shipments to the US. The companies' goal is to ensure this issue is on the radar of our Federal government administrations (e.g. ISED) and politicians. I plan to contact their offices (calls, emails, in person where possible) to make them aware of the risk to the Canadian CDMO industry, manufacturing jobs, and to Canada's Life Science commercialization strategy. My goal is for this issue to be on the agenda to address by our trade negotiators if and when trade negitiations resume so they can be reduced to something reasonable (e.g. Europe is 15% whereas Canada is 100%).Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.